Book a free demo
H-1B Data › Employers › Allogene Therapeutics, Inc.
Check another employer
H-1B Sponsor Profile

Allogene Therapeutics, Inc. — H-1B Visa Sponsorship Data

16 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.

South San Francisco, CAActive FY2021–FY2026Transfer-FriendlyFull-Time RolesNot H-1B Dependent
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
16 certified LCAs
FY2026 filings
1
most recent disclosure year
Median H-1B salary
$145,732
typical $129,754–$176,896
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
38%
change-of-employer filings

1 item a DOL auditor would ask Allogene Therapeutics, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Allogene Therapeutics, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

0 need attention1 to watch3 clear
Watch
1 certified LCA (1 position) end within 180 days

Next end date: 2026-11-30. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Clear
0% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage).

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
1 worksite across 1 state

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you Allogene Therapeutics, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Allogene Therapeutics, Inc.?

Does Allogene Therapeutics, Inc. sponsor H-1B visas?

Yes — Allogene Therapeutics, Inc. sponsors H-1B workers, with 16 certified LCAs on file (FY2021–FY2026), including 1 in FY2026. The median certified salary is $145,732 (P25 $129,754, P75 $176,896). With a 38% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Allogene Therapeutics, Inc.

Salary range
Median $145,732, typical band $129,754–$176,896.
Transfers
38% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
South San Francisco, CA.
Position type
100% of filings are full-time roles.
Common roles
Principal Scientist, Senior Manager, Quality And Regulatory, Manager – Sap Applications.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Allogene Therapeutics, Inc. has 16 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2026).

The median sponsored salary is $145,732, with a typical P25–P75 band of $129,754–$176,896 across certified LCAs.

Yes — 38% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

Allogene Therapeutics, Inc. filed 1 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include South San Francisco, CA.
Sponsorship data

Allogene Therapeutics, Inc. H-1B data at a glance

Executive Summary

Allogene Therapeutics, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).

  • Median certified salary is $145,732, typically $129,754–$176,896 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 38% — workers actively transfer to this employer.
  • Worksite footprint spans 1 state and 1 city.
  • Most-sponsored roles: Principal Scientist, Senior Manager, Quality And Regulatory S, Manager – Sap Applications.
  • Filed 1 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$120,000
$224,687
P25$129,754
Median$145,732
P75$176,896

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
0%
Level II
25%
Level III
25%
Level IV
50%

Levels I–IV are DOL prevailing-wage experience tiers; 75% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
4
FY2022
6
FY2023
4
FY2024
1
FY2026
1
Fiscal yearCertifiedDeniedWithdrawnTotal
FY20214004
FY20226006
FY20234004
FY20241001
FY20261001

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›FY2026 ›

All LCA filings

13 filings
Job titleSalaryLevelLocationFiledStatus
Senior Manager, Quality and Regulatory Systems
I-200-25270-339316
$224,687/yr—South San Francisco, CASep 26, 2025Certified
Scientist, Process Development
I-200-24121-942478
$129,016/yrIISouth San Francisco, CAApr 30, 2024Certified
Senior Scientist
I-200-23157-082820
$130,000/yrIIISouth San Francisco, CAJun 06, 2023Certified
Manager – SAP Applications
I-200-23073-847279
$176,947/yrIVSouth San Francisco, CAMar 14, 2023Certified
Senior Manager, Quality and Regulatory Systems
I-200-22279-515390
$197,970/yr—South San Francisco, CAOct 06, 2022Certified
Manager – SAP Applications
I-200-22213-388403
$175,000/yrIVSouth San Francisco, CAAug 01, 2022Certified
Scientist, Cell Engineering
I-200-22182-329139
$129,002/yrIVSouth San Francisco, CAJul 01, 2022Certified
Associate Director, CMC Regulatory Affairs
I-200-22158-251462
$176,879/yr—South San Francisco, CAJun 07, 2022Certified
Manager, Pharmacovigilance Operations
I-200-22145-209466
$153,149/yr—South San Francisco, CAMay 25, 2022Certified
Senior Scientist
I-200-22136-176543
$128,752/yrIIISouth San Francisco, CAMay 16, 2022Certified
Associate Director, External Quality
I-200-21343-753344
$160,000/yrIVSouth San Francisco, CADec 08, 2021Certified
Scientist, Process Development
I-200-21263-593940
$120,000/yrIISouth San Francisco, CASep 20, 2021Certified
Principal Scientist
I-200-20336-933630
$138,315/yr—South San Francisco, CADec 01, 2020Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Allogene Therapeutics, Inc. sponsors H-1B talent

Petition Mix

New employment  6%Transfer (change of employer)  38%Continued employment  56%
High transfer share (38%) — H-1B workers actively change employers to join Allogene Therapeutics, Inc..

Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Dec and May — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Principal Scientist
3 · $138,315
Senior Manager, Quality And Regula
3 · $206,876
Manager – Sap Applications
2 · $175,974
Scientist, Process Development
2 · $124,508
Senior Scientist
2 · $129,376

Top worksite locations

1 state · 1 city

South San Francisco, CA
16
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Allogene Therapeutics, Inc. · audit readiness
0 need attention1 to watch3 clear
Get my private gap check →